How Polycythemia Vera Medications Work

Polycythemia vera is a myeloproliferative disorder characterized by the overproduction of red blood cells, white blood cells, and platelets. The primary goal of treatment is to reduce the excessive cell production and alleviate symptoms.

Treatment Options

• Phlebotomy: Regular bloodletting is considered the gold standard for treating polycythemia vera. It reduces red blood cell count, alleviates symptoms, and decreases the risk of thrombosis.
• Chemotherapy: Hydroxyurea is a chemotherapy drug that slows down red blood cell production, reducing the risk of complications associated with increased cell counts.
• Immunomodulatory Therapy: Interferon-alpha can reduce white blood cell count and alleviate symptoms such as fatigue and dizziness.

Mechanism of Action

The medications used to treat polycythemia vera work by either reducing the production of red blood cells or alleviating symptoms associated with increased cell counts. Phlebotomy directly reduces red blood cell count, while hydroxyurea and interferon-alpha have a more indirect effect on cell production.